About this trial

The goal of this prospective study is to assess the correlation between coronary microvascular disfunction and insulin resistance in patients with INOCA.

Patients with ANOCA and without diabetes will undergo invasive coronary microvascular assessment through coronary angiography and insulin resistance assessment through hyperinsulinemic-euglycemic clamp test.

Patients enrolled in the study will be followed for a period of 2 years to monitor their clinical status.

Eligibility criteria

Qualifiers

Aged over 18 years.

Cardiac chest pain with evidence of myocardial ischemia at noninvasive myocardial stress imaging and clinical indication to diagnostic coronary angiography

Willing and able to give informed consent for participation in the study

Disqualifiers

Obstructive CAD (defined as more than 70% luminal stenosis and/or FFR ≤0.80 in 1 or more epicardial vessels).

History of previous myocardial infarction, percutaneous revascularization or coronary-aortic bypass graft (CABG) surgery.

Diagnosis of type II diabetes.

BMI ≥ 35 kg/m2.

Trial design

Treatments tested in this trial

  • Thermodilution based assessment of coronary microcirculation
  • Hyperinsulinemic-euglycemic Clamp test

Treatment groups

40 Participants
are divided into 1 treatment group

Locations

1
Azienda Ospedaliera Universitaria di Verona37126, VeronaVR, Italy

Sponsors and collaborators

Azienda Ospedaliera Universitaria Integrata Verona

Lead sponsor